Pilot Study of Meat-Borne Carcinogens and Pancreatic Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Pancreatic Cancer
Interventions
RADIATION

MeIQx

On the day of administration, the subject will swallow a capsule with a dietary relevant dose of MeIQx, 21 µg, labeled with a very low level of 14-carbon. The radioactive dose for MeIQx, 0.002 mSv (4.3 µCi), or less than an average dental x-ray.

PROCEDURE

Pancreatectomy

Patients with operable pancreatic cancer scheduled for a pancreatectomy at the University of Minnesota Medical Center.

Trial Locations (1)

55455

Masonic Cancer Center, University of Minnesota, Minneapolis

All Listed Sponsors
lead

University of Minnesota

OTHER

NCT01492907 - Pilot Study of Meat-Borne Carcinogens and Pancreatic Cancer | Biotech Hunter | Biotech Hunter